migraine-head
ESB Professional / shutterstock.com
9 July 2020EuropeMuireann Bolger

Teva loses TM appeal over ‘French version’ of slogan

Drug company  Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the  EU General Court ruled in favour of the  European Union IP Office (EUIPO) yesterday, July 8.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
7 January 2014   EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Big Pharma
18 July 2017   The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Big Pharma
19 October 2020   Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.

More on this story

Big Pharma
7 January 2014   EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Big Pharma
18 July 2017   The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Big Pharma
19 October 2020   Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.

More on this story

Big Pharma
7 January 2014   EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Big Pharma
18 July 2017   The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Big Pharma
19 October 2020   Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.